Adipo Therapeutics, LLC

Biotechnology company · Indianapolis, Indiana, United States

Adipo Therapeutics, LLC is a biotechnology company headquartered in Indianapolis, Indiana, United States. Its earliest recorded incorporation is in 2016. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $198,323 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $4.7 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Adipo Therapeutics at a glance

Typebiotechnology company
HeadquartersIndianapolis, Indiana, United States
Earliest incorporation on record2016
Employees (self-reported, 2018)1
SEC CIK1823434

What does Adipo Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $198,323 in total (2018). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $4.7 million sold (2024).

Frequently asked questions about Adipo Therapeutics

Where is Adipo Therapeutics headquartered?

Adipo Therapeutics, LLC is headquartered in Indianapolis, Indiana, United States.

What does Adipo Therapeutics do?

Adipo Therapeutics, LLC is a biotechnology company.

When was Adipo Therapeutics founded?

The earliest incorporation on record for Adipo Therapeutics, LLC is in 2016, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences